103 related articles for article (PubMed ID: 17653856)
1. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome.
Elsheikh S; Green AR; Aleskandarany MA; Grainge M; Paish CE; Lambros MB; Reis-Filho JS; Ellis IO
Breast Cancer Res Treat; 2008 May; 109(2):325-35. PubMed ID: 17653856
[TBL] [Abstract][Full Text] [Related]
2. Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers.
Vaziri SA; Tubbs RR; Darlington G; Casey G
Mol Pathol; 2001 Aug; 54(4):259-63. PubMed ID: 11477142
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneity of amplification of HER2, EGFR, CCND1 and MYC in gastric cancer.
Stahl P; Seeschaaf C; Lebok P; Kutup A; Bockhorn M; Izbicki JR; Bokemeyer C; Simon R; Sauter G; Marx AH
BMC Gastroenterol; 2015 Feb; 15():7. PubMed ID: 25649416
[TBL] [Abstract][Full Text] [Related]
4. 8p deletion is strongly linked to poor prognosis in breast cancer.
Lebok P; Mittenzwei A; Kluth M; Özden C; Taskin B; Hussein K; Möller K; Hartmann A; Lebeau A; Witzel I; Mahner S; Wölber L; Jänicke F; Geist S; Paluchowski P; Wilke C; Heilenkötter U; Simon R; Sauter G; Terracciano L; Krech R; von der Assen A; Müller V; Burandt E
Cancer Biol Ther; 2015; 16(7):1080-7. PubMed ID: 25961141
[TBL] [Abstract][Full Text] [Related]
5. Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas and Paired Normal Mucosae Reveals Cyclin D1 Deregulation and Compensatory Effect of Cyclin D2.
Novotný J; Bandúrová V; Strnad H; Chovanec M; Hradilová M; Šáchová J; Šteffl M; Grušanović J; Kodet R; Pačes V; Lacina L; Smetana K; Plzák J; Kolář M; Vomastek T
Cancers (Basel); 2020 Mar; 12(4):. PubMed ID: 32224897
[TBL] [Abstract][Full Text] [Related]
6. CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.
Valla M; Klæstad E; Ytterhus B; Bofin AM
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):67-77. PubMed ID: 35459982
[TBL] [Abstract][Full Text] [Related]
7. Association of CCND1 (c.723G > A, rs9344) variant with elevated risk of breast carcinoma: a retrospective case-control study.
El-Eshmawy MA; Shahin HE; El-Beltagy NS; Abdel Hamid D; Elfarargy OM; Elsayed DH; Elsaid AM; Elshazli RM; Mohamed NM
Mol Biol Rep; 2023 Mar; 50(3):2015-2024. PubMed ID: 36534235
[TBL] [Abstract][Full Text] [Related]
8. The overexpression of cyclin D1 is a positive prognostic factor in advanced-stage breast carcinoma cases.
Aksoy A; Sevim M; Artas G
North Clin Istanb; 2023; 10(6):726-733. PubMed ID: 38328730
[TBL] [Abstract][Full Text] [Related]
9. SP8 Transcriptional Regulation of
Borello U; Berarducci B; Delahaye E; Price DJ; Dehay C
Front Neurosci; 2018; 12():119. PubMed ID: 29599703
[TBL] [Abstract][Full Text] [Related]
10. Metastatic cyclin D1 positive lobular breast carcinoma as a potential lymphoma mimicker.
Ghani HA; Kavuri SB; Garcia JD; Zahner CJ; Lyapichev KA
EJHaem; 2023 Nov; 4(4):1174-1175. PubMed ID: 38024639
[No Abstract] [Full Text] [Related]
11. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
12. Effects of cyclin D1 gene amplification and protein expression on time to recurrence in postmenopausal breast cancer patients treated with anastrozole or tamoxifen: a TransATAC study.
Lundgren K; Brown M; Pineda S; Cuzick J; Salter J; Zabaglo L; Howell A; Dowsett M; Landberg G;
Breast Cancer Res; 2012 Apr; 14(2):R57. PubMed ID: 22475046
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: analysis of allele-specific expression.
Hosokawa Y; Arnold A
Genes Chromosomes Cancer; 1998 May; 22(1):66-71. PubMed ID: 9591636
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D as a therapeutic target in cancer.
Musgrove EA; Caldon CE; Barraclough J; Stone A; Sutherland RL
Nat Rev Cancer; 2011 Jul; 11(8):558-72. PubMed ID: 21734724
[TBL] [Abstract][Full Text] [Related]
15. Cyclin D1 amplification in multiple myeloma is associated with multidrug resistance expression.
Sewify EM; Afifi OA; Mosad E; Zaki AH; El Gammal SA
Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):215-22. PubMed ID: 24468132
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.
Lopez-Chavez A; Thomas A; Rajan A; Raffeld M; Morrow B; Kelly R; Carter CA; Guha U; Killian K; Lau CC; Abdullaev Z; Xi L; Pack S; Meltzer PS; Corless CL; Sandler A; Beadling C; Warrick A; Liewehr DJ; Steinberg SM; Berman A; Doyle A; Szabo E; Wang Y; Giaccone G
J Clin Oncol; 2015 Mar; 33(9):1000-7. PubMed ID: 25667274
[TBL] [Abstract][Full Text] [Related]
17. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
[TBL] [Abstract][Full Text] [Related]
18.
Chen Y; Huang Y; Gao X; Li Y; Lin J; Chen L; Chang L; Chen G; Guan Y; Pan LK; Xia X; Guo Z; Pan J; Xu Y; Yi X; Chen C
Front Immunol; 2020; 11():1620. PubMed ID: 32903763
[No Abstract] [Full Text] [Related]
19. Deciphering the Immune Microenvironment at the Forefront of Tumor Aggressiveness by Constructing a Regulatory Network with Single-Cell and Spatial Transcriptomic Data.
Xu K; Yu D; Zhang S; Chen L; Liu Z; Xie L
Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254989
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
